ATRICURE INC (ATRC) Stock Fundamental Analysis
USA - NASDAQ:ATRC - US04963C2098 - Common Stock
32.05 USD
+0.55 (+1.75%)
32.05 USD
0 (0%)
Overall ATRC gets a fundamental rating of 4 out of 10. We evaluated ATRC against 189 industry peers in the Health Care Equipment & Supplies industry. While ATRC seems to be doing ok healthwise, there are quite some concerns on its profitability. ATRC is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
ATRC had negative earnings in the past year.
ATRC had a positive operating cash flow in the past year.
ATRC had negative earnings in 4 of the past 5 years.
In multiple years ATRC reported negative operating cash flow during the last 5 years.
1.2 Ratios
With a decent Return On Assets value of -5.97%, ATRC is doing good in the industry, outperforming 65.61% of the companies in the same industry.
With a decent Return On Equity value of -7.83%, ATRC is doing good in the industry, outperforming 67.20% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.97% | ||
| ROE | -7.83% | ||
| ROIC | N/A |
ROA(3y)-6.75%
ROA(5y)-3.76%
ROE(3y)-8.8%
ROE(5y)-5.54%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Gross Margin value of 74.71%, ATRC belongs to the best of the industry, outperforming 86.24% of the companies in the same industry.
In the last couple of years the Gross Margin of ATRC has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for ATRC so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 74.71% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y0.24%
2. Health
2.1 Basic Checks
ATRC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ATRC has been increased compared to 1 year ago.
Compared to 5 years ago, ATRC has more shares outstanding
The debt/assets ratio for ATRC is higher compared to a year ago.
2.2 Solvency
ATRC has an Altman-Z score of 6.70. This indicates that ATRC is financially healthy and has little risk of bankruptcy at the moment.
ATRC's Altman-Z score of 6.70 is amongst the best of the industry. ATRC outperforms 85.71% of its industry peers.
ATRC has a debt to FCF ratio of 8.42. This is a slightly negative value and a sign of low solvency as ATRC would need 8.42 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 8.42, ATRC is doing good in the industry, outperforming 74.07% of the companies in the same industry.
A Debt/Equity ratio of 0.15 indicates that ATRC is not too dependend on debt financing.
ATRC has a Debt to Equity ratio (0.15) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 8.42 | ||
| Altman-Z | 6.7 |
ROIC/WACCN/A
WACC8.66%
2.3 Liquidity
ATRC has a Current Ratio of 3.94. This indicates that ATRC is financially healthy and has no problem in meeting its short term obligations.
ATRC has a better Current ratio (3.94) than 68.78% of its industry peers.
ATRC has a Quick Ratio of 2.83. This indicates that ATRC is financially healthy and has no problem in meeting its short term obligations.
ATRC has a Quick ratio of 2.83. This is in the better half of the industry: ATRC outperforms 66.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.94 | ||
| Quick Ratio | 2.83 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 69.88% over the past year.
ATRC shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.80%.
Measured over the past years, ATRC shows a quite strong growth in Revenue. The Revenue has been growing by 15.05% on average per year.
EPS 1Y (TTM)69.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.12%
Revenue 1Y (TTM)15.8%
Revenue growth 3Y19.26%
Revenue growth 5Y15.05%
Sales Q2Q%15.84%
3.2 Future
ATRC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.01% yearly.
Based on estimates for the next years, ATRC will show a quite strong growth in Revenue. The Revenue will grow by 13.24% on average per year.
EPS Next Y40.44%
EPS Next 2Y31.48%
EPS Next 3Y31.18%
EPS Next 5Y23.01%
Revenue Next Year15.08%
Revenue Next 2Y13.68%
Revenue Next 3Y13.55%
Revenue Next 5Y13.24%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
ATRC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ATRC. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
67.72% of the companies in the same industry are more expensive than ATRC, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 192.22 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
ATRC's earnings are expected to grow with 31.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.48%
EPS Next 3Y31.18%
5. Dividend
5.1 Amount
ATRC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
32.05
+0.55 (+1.75%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners100.55%
Inst Owner Change0.15%
Ins Owners3.41%
Ins Owner Change0.97%
Market Cap1.59B
Revenue(TTM)518.30M
Net Income(TTM)-36.36M
Analysts85.33
Price Target52.02 (62.31%)
Short Float %4.26%
Short Ratio5.27
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)64.19%
Min EPS beat(2)40.06%
Max EPS beat(2)88.31%
EPS beat(4)4
Avg EPS beat(4)52.14%
Min EPS beat(4)14.39%
Max EPS beat(4)88.31%
EPS beat(8)7
Avg EPS beat(8)29.57%
EPS beat(12)10
Avg EPS beat(12)31.55%
EPS beat(16)11
Avg EPS beat(16)69.13%
Revenue beat(2)1
Avg Revenue beat(2)0.57%
Min Revenue beat(2)-1.4%
Max Revenue beat(2)2.54%
Revenue beat(4)2
Avg Revenue beat(4)0.59%
Min Revenue beat(4)-1.4%
Max Revenue beat(4)2.54%
Revenue beat(8)3
Avg Revenue beat(8)0.09%
Revenue beat(12)6
Avg Revenue beat(12)0.47%
Revenue beat(16)9
Avg Revenue beat(16)0.75%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0.96%
EPS NQ rev (3m)12.9%
EPS NY rev (1m)16.13%
EPS NY rev (3m)22.94%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.5%
Revenue NY rev (3m)1.99%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 3.19 | ||
| P/FCF | 192.22 | ||
| P/OCF | 43.72 | ||
| P/B | 3.43 | ||
| P/tB | 8.98 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.25
EYN/A
EPS(NY)-0.19
Fwd EYN/A
FCF(TTM)0.17
FCFY0.52%
OCF(TTM)0.73
OCFY2.29%
SpS10.06
BVpS9.35
TBVpS3.57
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.97% | ||
| ROE | -7.83% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 74.71% | ||
| FCFM | 1.66% |
ROA(3y)-6.75%
ROA(5y)-3.76%
ROE(3y)-8.8%
ROE(5y)-5.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y0.24%
F-Score4
Asset Turnover0.82
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 8.42 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 140.66% | ||
| Cap/Sales | 5.63% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.94 | ||
| Quick Ratio | 2.83 | ||
| Altman-Z | 6.7 |
F-Score4
WACC8.66%
ROIC/WACCN/A
Cap/Depr(3y)184.3%
Cap/Depr(5y)140.27%
Cap/Sales(3y)6.89%
Cap/Sales(5y)5.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)69.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.12%
EPS Next Y40.44%
EPS Next 2Y31.48%
EPS Next 3Y31.18%
EPS Next 5Y23.01%
Revenue 1Y (TTM)15.8%
Revenue growth 3Y19.26%
Revenue growth 5Y15.05%
Sales Q2Q%15.84%
Revenue Next Year15.08%
Revenue Next 2Y13.68%
Revenue Next 3Y13.55%
Revenue Next 5Y13.24%
EBIT growth 1Y2.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year242.67%
EBIT Next 3Y62.94%
EBIT Next 5Y43.19%
FCF growth 1Y117.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1396.48%
OCF growth 3YN/A
OCF growth 5YN/A
ATRICURE INC / ATRC FAQ
What is the fundamental rating for ATRC stock?
ChartMill assigns a fundamental rating of 4 / 10 to ATRC.
What is the valuation status of ATRICURE INC (ATRC) stock?
ChartMill assigns a valuation rating of 2 / 10 to ATRICURE INC (ATRC). This can be considered as Overvalued.
What is the profitability of ATRC stock?
ATRICURE INC (ATRC) has a profitability rating of 3 / 10.
What is the earnings growth outlook for ATRICURE INC?
The Earnings per Share (EPS) of ATRICURE INC (ATRC) is expected to grow by 40.44% in the next year.